E-Pearl of the Week: Clinical spectrum of CNS aquaporin–4 autoimmunity

April 10, 2012

Share:

Interested in submitting an e–Pearl? Click here!

Brought to you by the Resident and Fellow Section of Neurology®.

April 10, 2012

Clinical spectrum of CNS aquaporin–4 autoimmunity

Neuromyelitis optica or NMO is an autoimmune inflammatory disease of the central nervous system characterized by severe attacks of optic neuritis and longitudinally extensive transverse myelitis. Anti–aquaporin 4 antibody is specific to NMO but is also associated with isolated optic neuritis or isolated longitudinally extensive transverse myelitis. About 25% of patients present with brain symptoms as their first manifestation, most commonly brain stem symptoms including vomiting and hiccups and cerebral symptoms including mental change and hemiparesis.

Reference

1. Kim S–H, Kim W, Li X, Jung I–J and Kim H. Clinical spectrum of CNS aquaporin–4 autoimmunity. Neurology 2012; 78: 1058–1063

Disclosure: Dr. Karam serves on the editorial team for the Neurology Resident and Fellow Section.

For more clinical pearls and other articles of interest to neurology trainees, visit www.neurology.org and click on the link to the Resident and Fellow Pages. Click here to visit the E–Pearl of the Week Archive.

Click here to listen to this week's Neurology® Podcast.